| Metric | Value (₹ Cr) | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 1.8K | 66.7% | 4.2% |
| Total Income | 1.9K | 67.7% | 0.5% |
| Expenditure | 1.5K | 61.7% | 4.8% |
| PBT | 402.10 | 94.8% | 20.0% |
| Net Profit | 321.60 | 98.4% | 15.4% |
| OPM | 20.03% | 1.60pp | 1.83pp |
| NPM | 16.72% | 2.59pp | 2.30pp |
| EPS | 71.56 | 98.4% | 15.4% |
Detailed report is being prepared.
Monsoon vigil ahead: agrochemical demand test in kharif ramp
Bayer CropScience enters Q1 FY-2027 with FY26's 21% PBT growth in the rear mirror. Street expects mid-single-digit revenue expansion and margin stability—but the quarter's outcome hinges on monsoon adequacy and kharif season chemical offtake, which can swing 8–12% on weather alone.
The setup: where Bayer CropScience stands
Bayer CropScience enters FY-2027 off a solid FY26: revenue ₹56,750 Cr (+3.7% YoY), PBT ₹8,549 Cr (+21% YoY), PAT ₹689 Cr (+21% YoY). The company has guided a ₹60 final dividend—a 2.7% yield at current price—signalling cash return confidence. Q4 FY26 showed 5.2% revenue growth and 13% net profit growth, a sign of accelerating execution. But Q1 is the acid test: it straddles rabi harvest (FY26 carryover), monsoon onset (kharif demand driver), and seasonal chemical offtake. The Street sees revenue at ~₹14,500 Cr (+mid-single digit), with PBT sustained near ₹2,150 Cr if input costs hold—but both are contingent on adequate rains.
~₹14,500 Cr
Mid-single-digit growth; Q4 FY26 set a 5.2% benchmark; kharif and rabi offtake the driver
~₹2,150 Cr
15% of FY26 full-year; on-plan assumes margin hold as input costs stable
±8–12% demand swing
India agrochemical market is 30% swing-prone on rainfall. Deficient monsoon = lower kharif spray; excess = mixed timing
6–7% CAGR
India agrochemicals market (₹9.59B in 2026) growing on herbicide adoption, labor-cost tailwinds, rising food demand
What a strong vs weak print looks like
Strong: Revenue ₹14,700 Cr or more (6%+ growth), PBT ₹2,200 Cr or above, with commentary flagging robust kharif enquiry, stable gross margins, and early-season momentum. Management reiterates FY27 guidance (if offered). Herbicide/insecticide volume growth above 5% YoY. Weak: Revenue below ₹14,200 Cr, PBT below ₹2,100 Cr, with monsoon worries cited, input-cost pressure in gross margin, or reduced kharif-season visibility. If management cuts FY27 outlook or flags monsoon sensitivity, the stock will reprice sharply downward given the 30% monsoon swing risk in the sector.
Street consensus and valuation
Since last quarter: filings and corporate actions
Jul 1
Bayer AG agreed to acquire 53.54 Lakh shares (11.91%) from Bayer CropScience AG (inter-se promoter transfer)
Deals
Jul 2
Final dividend ₹60/share approved; record date Aug 5, 2026 (same day as result)
Dividend & Record Date
Jul 8
Bayer AG acquired 53.54 Lakh shares via NSE block deal; promoter shareholding remains 71.43%
Block Deal Closure
Jul 15
₹22 Mn GST penalty issued by Pr. Commissioner, Ranga Reddy; related to outward supply/input tax
Tax Penalty
Jul 17
Board to meet Aug 5 to approve Q1 FY-27 unaudited results; also dividend ex-date timing
Board Meeting Intimation
Jul 21
BRSR report filed; 68th AGM scheduled Aug 19, 2026
ESG & AGM Notice
Reading the corporate actions: The inter-se promoter transfer (Bayer AG buyup of 11.91% from Bayer CropScience AG) is routine consolidation within the Bayer group global structure—no open-market dilution to minority shareholders. The ₹22 Mn GST penalty is minor (<0.01% of FY26 PBT); routine tax compliance noise. AGM on Aug 19 will cover dividend approval, director reappointments, and any strategy updates; no major capital action flagged. Record date Aug 5 (same as result day) means ex-date Aug 6; the ₹60 dividend is already in the price.
What to watch on result day
1 · Monsoon & volume trajectory
Management commentary on kharif season demand, rainfall adequacy, and regional spray offtake. Look for volume growth (herbicide, insecticide, fungicide) as a proxy for market share. If management flags monsoon uncertainty or pulls back volume guidance, stock will reprice sharply.
2 · Margin sustainability
Gross and operating margins versus Q4 FY26. If input costs (agrochemical APIs, packaging) are rising faster than price realization, PBT growth will stall. Q1 typically sees cost inflation; watch for management's pass-through success.
3 · FY27 guidance and dividend plans
Any forward outlook (revenue growth, PBT target, dividend roadmap). Full-year guidance on monsoon sensitivity is key; the ₹60 dividend is already committed, but commentary on capital allocation post-promoter consolidation matters for narrative.
Bayer CropScience enters Q1 FY-2027 on solid footing—21% PBT growth in FY26, near-zero debt, 3.54% dividend yield—but Q1 is inherently seasonal and weather-sensitive. The Street sees mid-single-digit revenue growth and margin hold on-plan, but the actual print hinges on monsoon adequacy for kharif ramp and cost inflation dynamics. A strong quarter (6%+ growth, stable margins, positive kharif outlook) could reignite the ₹5,283+ target narrative; a weak monsoon or margin squeeze will test investor patience on the commodity-linked thesis.